BANK OF AMERICA CORP /DE/
BankPosition in IPSC — Century Therapeutics, Inc.
CIK 70858
CHARLOTTE, NC
Position in IPSC
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$389,286
+$61,363 QoQ
Shares Held
158,893
+9.5% QoQ
Ownership
0.088%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#38
of 98 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IPSC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. IPSC ranks #254 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in IPSC
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $389,286 | 158,893 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $327,923 | 145,099 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $521 | 525 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $297 | 598 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $1,838 | 3,290 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $13,742 | 28,873 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $66,703 | 66,043 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $53,996 | 31,577 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $75,474 | 29,598 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $176,993 | 42,343 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $142,390 | 42,889 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $80,720 | 40,360 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $168,199 | 53,228 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $247,371 | 71,289 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $219,335 | 42,756 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $336,971 | 34,072 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $302,533 | 36,016 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $576,054 | 45,755 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $652,257 | 41,126 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $699,019 | 27,783 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $293 | 10 | Shares | Defined | 2021-09-13 | |
| No filing history on record for this holder in this stock. | ||||||